| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| AMIXAutonomix Medical, Inc. Common Stock | 3.59M | 0.52 | -0.08 | -258.98% | ||||
| CBLLCeriBell, Inc. | 847.27M | 22.84 | -6.74 | 44.71% | -63.35% | -31.97% | 0.11 | |
| NMTCNeuroOne Medical Technologies Corporation | 45.32M | 0.90 | -9.99 | 250.35% | -39.63% | -50.98% | 0.04 | |
| CLPTClearPoint Neuro, Inc. | 435.81M | 14.65 | -20.93 | 31.04% | -67.4% | -145.77% | 0.14 |
| Dec 2016 | Dec 2017 | Sep 2018 | Sep 2019 | Sep 2020 | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 1.93M | 178.15K | 171.17K | 1.95M | 3.45M | 12.1M |
| Revenue Growth % | -1% | - | - | - | - | -0.91% | -0.04% | 10.41% | 0.77% | 2.5% |
| Cost of Goods Sold | 7.74K | 17.63K | 21.67K | 27.57K | 70.55K | 275.89K | 241.96K | 1.5M | 2.37M | 3.96M |
| COGS % of Revenue | - | - | - | - | 0.04% | 1.55% | 1.41% | 0.77% | 0.69% | 0.33% |
| Gross Profit | -7.74K | -17.63K | -21.67K | -27.57K | 1.86M | -97.75K | -70.79K | 456.52K | 1.08M | 8.14M |
| Gross Margin % | - | - | - | - | 0.96% | -0.55% | -0.41% | 0.23% | 0.31% | 0.67% |
| Gross Profit Growth % | -11.43% | -1.28% | -0.23% | -0.27% | 68.32% | -1.05% | 0.28% | 7.45% | 1.37% | 6.54% |
| Operating Expenses | 32.61K | 3.07M | 3.19M | 5.81M | 6.76M | 10.12M | 9.96M | 12.41M | 12.97M | 12.37M |
| OpEx % of Revenue | - | - | - | - | 3.51% | 56.81% | 58.19% | 6.36% | 3.76% | 1.02% |
| Selling, General & Admin | 32.61K | 2.34M | 3.54M | 4.28M | 4.75M | 6.26M | 6.98M | 6.93M | 7.9M | 7.38M |
| SG&A % of Revenue | - | - | - | - | 2.47% | 35.14% | 40.77% | 3.55% | 2.29% | 0.61% |
| Research & Development | 0 | 735.33K | 951.06K | 1.53M | 2.08M | 3.93M | 4.93M | 6.94M | 5.07M | 4.98M |
| R&D % of Revenue | - | - | - | - | 1.08% | 22.03% | 28.8% | 3.55% | 1.47% | 0.41% |
| Other Operating Expenses | 0 | 0 | -1.3M | 0 | -70.55K | -64.81K | -1.95M | -1.46M | 0 | 0 |
| Operating Income | -32.61K | -3.07M | -3.21M | -5.81M | -4.9M | -10.22M | -10.03M | -11.96M | -11.89M | -4.23M |
| Operating Margin % | - | - | - | - | -2.54% | -57.36% | -58.6% | -6.12% | -3.44% | -0.35% |
| Operating Income Growth % | -0.05% | -93.21% | -0.05% | -0.81% | 0.16% | -1.08% | 0.02% | -0.19% | 0.01% | 0.64% |
| EBITDA | -24.87K | -3.05M | -3.19M | -5.79M | -4.83M | -10.07M | -9.91M | -11.76M | -11.64M | -3.96M |
| EBITDA Margin % | - | - | - | - | -2.51% | -56.53% | -57.91% | -6.02% | -3.37% | -0.33% |
| EBITDA Growth % | -0.07% | -121.82% | -0.04% | -0.81% | 0.16% | -1.08% | 0.02% | -0.19% | 0.01% | 0.66% |
| D&A (Non-Cash Add-back) | 7.74K | 17.63K | 21.67K | 27.57K | 70.55K | 147.13K | 118.62K | 199.27K | 246.79K | 261.68K |
| EBIT | -189.73K | -3.07M | -4.17M | -5.81M | -4.9M | -9.95M | -10.03M | -11.96M | -12.09M | -3.27M |
| Net Interest Income | 0 | 0 | 0 | 0 | -7.52M | -3.05K | 0 | 0 | -228.99K | 0 |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 1.4M | 0 | 284.56K | 7.52M | 3.05K | 0 | 0 | 228.99K | 0 |
| Other Income/Expense | 156.71K | -1.99M | -2.66M | -967.77K | -8.74M | 270.04K | 31.15K | 95.76K | -430.9K | 621.1K |
| Pretax Income | -32.61K | -5.06M | -6.83M | -6.78M | -13.64M | -9.95M | -10M | -11.86M | -12.32M | -3.61M |
| Pretax Margin % | - | - | - | - | -7.08% | -55.84% | -58.42% | -6.07% | -3.57% | -0.3% |
| Income Tax | 15.16K | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 1.46% | 1% | 1% | 1% | 1% | 1% | 1% | 1% | 1% | 1% |
| Net Income | -47.77K | -5.06M | -6.83M | -6.78M | -13.64M | -9.95M | -10M | -11.86M | -12.32M | -3.61M |
| Net Margin % | - | - | - | - | -7.08% | -55.84% | -58.42% | -6.07% | -3.57% | -0.3% |
| Net Income Growth % | 0.24% | -104.88% | -0.35% | 0.01% | -1.01% | 0.27% | -0.01% | -0.19% | -0.04% | 0.71% |
| Net Income (Continuing) | -284.97K | -5.06M | -6.83M | -6.78M | -13.64M | -9.95M | -10M | -11.86M | -12.32M | -3.61M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.03 | -2.30 | -2.43 | -1.72 | -2.52 | -0.93 | -0.63 | -0.65 | -0.46 | -0.09 |
| EPS Growth % | 0.24% | -80.27% | -0.06% | 0.29% | -0.47% | 0.63% | 0.32% | -0.03% | 0.29% | 0.8% |
| EPS (Basic) | -0.03 | -2.30 | -2.43 | -1.72 | -2.52 | -0.93 | -0.63 | -0.65 | -0.46 | -0.09 |
| Diluted Shares Outstanding | 1.69M | 2.2M | 2.81M | 3.95M | 5.42M | 10.7M | 16M | 18.12M | 26.76M | 40.15M |
| Basic Shares Outstanding | 1.69M | 2.2M | 2.81M | 3.95M | 5.42M | 10.7M | 16M | 18.12M | 26.76M | 40.15M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
| Dec 2016 | Dec 2017 | Sep 2018 | Sep 2019 | Sep 2020 | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 576.04K | 33.61K | 18.64K | 301.75K | 4.16M | 7.29M | 12.18M | 7.31M | 4.63M | 10.23M |
| Cash & Short-Term Investments | 522.22K | 26.47K | 13.26K | 260.75K | 4.04M | 6.9M | 11.14M | 5.32M | 1.46M | 6.57M |
| Cash Only | 522.22K | 26.47K | 13.26K | 260.75K | 4.04M | 6.9M | 8.16M | 5.32M | 1.46M | 6.57M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 2.98M | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 48.34K | 33.24K | 0 | 176.64K | 1.26M |
| Days Sales Outstanding | - | - | - | - | - | 99.03 | 70.87 | - | 18.67 | 38.16 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 98.29K | 704.54K | 1.73M | 2.64M | 2.23M |
| Days Inventory Outstanding | - | - | - | - | - | 130.03 | 1.06K | 421.31 | 405.27 | 205.44 |
| Other Current Assets | 0 | 0 | 0 | 0 | 601 | 92.93K | 0 | 0 | 142.63K | 22.92K |
| Total Non-Current Assets | 180.89K | 216.37K | 200.08K | 230.86K | 604.76K | 646.48K | 646.85K | 784.39K | 739.01K | 559.36K |
| Property, Plant & Equipment | 0 | 0 | 0 | 52.03K | 448.24K | 512.28K | 534.95K | 694.81K | 671.75K | 514.42K |
| Fixed Asset Turnover | - | - | - | - | 4.30x | 0.35x | 0.32x | 2.81x | 5.14x | 23.52x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 180.89K | 216.37K | 200.08K | 178.84K | 156.52K | 134.21K | 111.89K | 89.58K | 67.26K | 44.95K |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 756.93K | 249.99K | 218.72K | 532.62K | 4.76M | 7.94M | 12.82M | 8.1M | 5.37M | 10.79M |
| Asset Turnover | - | - | - | - | 0.40x | 0.02x | 0.01x | 0.24x | 0.64x | 1.12x |
| Asset Growth % | 410.82% | -0.67% | -0.13% | 1.44% | 7.94% | 0.67% | 0.62% | -0.37% | -0.34% | 1.01% |
| Total Current Liabilities | 677.19K | 3.91M | 3.8M | 1.77M | 2.36M | 1.18M | 3.1M | 1.79M | 2.21M | 2.3M |
| Accounts Payable | 22.36K | 0 | 221.24K | 1.15M | 762.54K | 528.83K | 927.66K | 685.1K | 1.03M | 1.01M |
| Days Payables Outstanding | 1.05K | - | 3.73K | 15.26K | 3.94K | 699.62 | 1.4K | 167.16 | 158.28 | 93.21 |
| Short-Term Debt | 275.2K | 2.42M | 1.68M | 0 | 1.01M | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 73.76K | 0 | 0 | 0 | 73.43K | 8.62K | 1000K | 0 | 0 | 0 |
| Other Current Liabilities | 351.38K | 1.26M | 512.39K | 50.4K | 166.3K | 0 | 0 | 0 | 59.95K | 1.44K |
| Current Ratio | 0.85x | 0.01x | 0.00x | 0.17x | 1.76x | 6.17x | 3.93x | 4.08x | 2.09x | 4.44x |
| Quick Ratio | 0.85x | 0.01x | 0.00x | 0.17x | 1.76x | 6.09x | 3.70x | 3.12x | 0.90x | 3.47x |
| Cash Conversion Cycle | - | - | - | - | - | -470.56 | -265.71 | - | 265.65 | 150.39 |
| Total Non-Current Liabilities | 345.96K | 1.38M | 817.15K | 0 | 337.66K | 202.9K | 119.56K | 55.28K | 2.33M | 1.41M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 254.33K | 202.9K | 119.56K | 55.28K | 194.39K | 143.15K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 345.96K | 1.38M | 817.15K | 0 | 83.33K | 0 | 0 | 0 | 2.14M | 1.27M |
| Total Liabilities | 1.02M | 5.29M | 4.61M | 1.77M | 2.69M | 1.38M | 3.22M | 1.85M | 4.55M | 3.71M |
| Total Debt | 275.2K | 2.42M | 1.68M | 0 | 1.32M | 315.67K | 202.9K | 184.4K | 260.16K | 266.81K |
| Net Debt | -247.02K | 2.39M | 1.66M | -260.75K | -2.72M | -6.59M | -7.96M | -5.14M | -1.2M | -6.3M |
| Debt / Equity | - | - | - | - | 0.64x | 0.05x | 0.02x | 0.03x | 0.32x | 0.04x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | -2.20x | - | -20.43x | -0.65x | -3346.94x | - | - | -51.91x | - |
| Total Equity | -266.22K | -5.04M | -4.4M | -1.24M | 2.07M | 6.55M | 9.6M | 6.25M | 822.01K | 7.07M |
| Equity Growth % | -2.27% | -17.92% | 0.13% | 0.72% | 2.67% | 2.17% | 0.47% | -0.35% | -0.87% | 7.6% |
| Book Value per Share | -0.16 | -2.29 | -1.57 | -0.31 | 0.38 | 0.61 | 0.60 | 0.34 | 0.03 | 0.18 |
| Total Shareholders' Equity | -266.22K | -5.04M | -4.4M | -1.24M | 2.07M | 6.55M | 9.6M | 6.25M | 822.01K | 7.07M |
| Common Stock | 31 | 7.87K | 9.66K | 13.49K | 22.18K | 12.01K | 16.22K | 23.93K | 30.82K | 50.01K |
| Retained Earnings | -266.37K | -5.32M | -10.46M | -17.24M | -30.88M | -40.83M | -50.83M | -62.69M | -75M | -78.61M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dec 2016 | Dec 2017 | Sep 2018 | Sep 2019 | Sep 2020 | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -21.11K | -2.11M | -2.83M | -5.4M | -3.43M | -8.6M | -7.52M | -12.89M | -11.01M | -2.84M |
| Operating CF Margin % | - | - | - | - | -1.78% | -48.29% | -43.93% | -6.6% | -3.19% | -0.23% |
| Operating CF Growth % | 0.3% | -98.88% | -0.34% | -0.91% | 0.37% | -1.51% | 0.13% | -0.71% | 0.15% | 0.74% |
| Net Income | -47.77K | -5.06M | -6.76M | -6.78M | -13.64M | -9.95M | -10M | -11.86M | -12.32M | -3.61M |
| Depreciation & Amortization | 7.74K | 17.63K | 20.56K | 27.57K | 47.61K | 80.75K | 118.62K | 199.27K | 246.79K | 261.68K |
| Stock-Based Compensation | 0 | 76.79K | 486.12K | 491.75K | 1.84M | 1.79M | 947.21K | 1.11M | 1.34M | 1.26M |
| Deferred Taxes | 0 | 590.97K | 0 | 683.21K | 2.02M | -85.31K | -11.47K | 0 | 0 | 0 |
| Other Non-Cash Items | 15.62K | 2M | 3.42M | 284.56K | 6.74M | 69.44K | 212.16K | 96.4K | 669.61K | -758.18K |
| Working Capital Changes | 11.05K | 859.89K | 1.77K | -101.88K | -429.56K | -512.73K | 1.21M | -2.43M | -954.61K | 0 |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | -48.34K | 15.1K | 33.24K | -176.64K | -1.09M |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | -98.29K | -606.25K | -1.02M | -908.47K | 10K |
| Change in Payables | 11.51K | 0 | 0 | 770.61K | -269.6K | -350.31K | 515.44K | -247.19K | 66.99K | 239.98K |
| Cash from Investing | 0 | -91.71K | -146.71K | -123.35K | -122.43K | -67.08K | -3.24M | 2.65M | -120.2K | -81.74K |
| Capital Expenditures | 0 | -91.71K | 0 | -123.35K | -122.43K | -67.08K | -275.23K | -384.12K | -120.2K | -81.74K |
| CapEx % of Revenue | - | - | - | - | 0.06% | 0.38% | 1.61% | 0.2% | 0.03% | 0.01% |
| Acquisitions | - | - | - | - | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | -91.71K | -146.71K | -65K | 0 | 0 | -2.97M | 7.5K | 0 | 0 |
| Cash from Financing | 21.11K | 1.7M | 2.92M | 5.77M | 7.32M | 11.53M | 12.02M | 7.4M | 7.27M | 141.42K |
| Debt Issued (Net) | - | - | - | - | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - | - | - | - | - |
| Other Financing | 21.11K | 749.9K | 2.92M | 1.49M | -1.51M | 2.71M | -1.33M | -1.07M | 1.48M | 141.42K |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | -21.11K | -2.2M | -2.83M | -5.52M | -3.55M | -8.67M | -7.79M | -13.27M | -11.13M | -2.92M |
| FCF Margin % | - | - | - | - | -1.84% | -48.67% | -45.54% | -6.8% | -3.22% | -0.24% |
| FCF Growth % | 0.3% | -103.23% | -0.29% | -0.95% | 0.36% | -1.44% | 0.1% | -0.7% | 0.16% | 0.74% |
| FCF per Share | -0.01 | -1.00 | -1.01 | -1.40 | -0.66 | -0.81 | -0.49 | -0.73 | -0.42 | -0.07 |
| FCF Conversion (FCF/Net Income) | 0.44x | 0.42x | 0.41x | 0.80x | 0.25x | 0.86x | 0.75x | 1.09x | 0.89x | 0.79x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | - | - | - | -3292.36% | -230.81% | -123.77% | -149.61% | -348.39% | -91.34% |
| Return on Invested Capital (ROIC) | - | - | - | - | - | - | -931.56% | -650.16% | -2431.11% | -1621.09% |
| Gross Margin | - | - | - | - | 96.34% | -54.87% | -41.36% | 23.38% | 31.27% | 67.3% |
| Net Margin | - | - | - | - | -708% | -5584.28% | -5841.95% | -607.42% | -356.74% | -29.8% |
| Debt / Equity | - | - | - | - | 0.64x | 0.05x | 0.02x | 0.03x | 0.32x | 0.04x |
| Interest Coverage | - | -2.20x | - | -20.43x | -0.65x | -3346.94x | - | - | -51.91x | - |
| FCF Conversion | 0.44x | 0.42x | 0.41x | 0.80x | 0.25x | 0.86x | 0.75x | 1.09x | 0.89x | 0.79x |
| Revenue Growth | -100% | - | - | - | - | -90.75% | -3.92% | 1040.65% | 76.86% | 250.35% |
NeuroOne Medical Technologies Corporation (NMTC) reported $9.1M in revenue for fiscal year 2025. This represents a 987706% increase from $0.0M in 2012.
NeuroOne Medical Technologies Corporation (NMTC) grew revenue by 250.4% over the past year. This is strong growth.
NeuroOne Medical Technologies Corporation (NMTC) reported a net loss of $3.6M for fiscal year 2025.
NeuroOne Medical Technologies Corporation (NMTC) has a return on equity (ROE) of -91.3%. Negative ROE indicates the company is unprofitable.
NeuroOne Medical Technologies Corporation (NMTC) had negative free cash flow of $2.9M in fiscal year 2025, likely due to heavy capital investments.